CRISAFULLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 3.571
EU - Europa 2.976
AS - Asia 2.438
OC - Oceania 68
SA - Sud America 42
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.117
Nazione #
US - Stati Uniti d'America 3.467
CN - Cina 1.383
IT - Italia 1.325
SG - Singapore 309
GB - Regno Unito 279
DE - Germania 243
FR - Francia 223
JP - Giappone 221
IE - Irlanda 125
SE - Svezia 123
HK - Hong Kong 117
ES - Italia 99
IN - India 88
FI - Finlandia 86
CA - Canada 79
KR - Corea 65
NL - Olanda 55
TW - Taiwan 55
ID - Indonesia 53
BE - Belgio 51
AT - Austria 47
PL - Polonia 47
AU - Australia 44
UA - Ucraina 41
IL - Israele 34
DK - Danimarca 33
CH - Svizzera 28
GR - Grecia 28
NZ - Nuova Zelanda 24
VN - Vietnam 23
MX - Messico 22
BR - Brasile 21
HU - Ungheria 20
NO - Norvegia 20
PT - Portogallo 20
RU - Federazione Russa 20
CZ - Repubblica Ceca 19
TR - Turchia 15
RO - Romania 14
AR - Argentina 11
BA - Bosnia-Erzegovina 11
IR - Iran 11
TH - Thailandia 11
MY - Malesia 10
AM - Armenia 8
EG - Egitto 6
HR - Croazia 6
AE - Emirati Arabi Uniti 5
ZA - Sudafrica 5
BN - Brunei Darussalam 4
KZ - Kazakistan 4
PK - Pakistan 4
RS - Serbia 4
CL - Cile 3
CO - Colombia 3
CY - Cipro 3
JO - Giordania 3
PE - Perù 3
SA - Arabia Saudita 3
AP - ???statistics.table.value.countryCode.AP??? 2
DZ - Algeria 2
EU - Europa 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
SN - Senegal 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
HN - Honduras 1
JM - Giamaica 1
LK - Sri Lanka 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 9.117
Città #
Ann Arbor 427
Chandler 275
Singapore 249
Beijing 219
Santa Clara 185
Shanghai 177
Redwood City 146
Milan 139
Guangzhou 130
Houston 130
Torino 126
Fairfield 121
Turin 120
Dublin 115
Ashburn 97
Cambridge 93
Woodbridge 79
Seattle 78
New York 76
Tokyo 69
Wilmington 66
Dearborn 61
Nanjing 56
Columbus 53
Boston 51
Rome 51
Hangzhou 49
Jakarta 47
Nyköping 46
Wuhan 43
Vienna 41
Lappeenranta 40
Pisa 36
Villeurbanne 34
London 33
Paris 32
Changsha 31
Los Angeles 31
Genoa 30
Carrara 29
Brussels 28
Medford 27
Helsinki 26
Barcelona 25
Taipei 25
Baltimore 24
Munich 24
San Diego 24
Berlin 23
Boardman 23
Central 23
Princeton 23
Jacksonville 22
Bologna 20
Central District 20
Fremont 20
Warsaw 20
Chongqing 19
Jinan 19
Luni 19
San Francisco 18
Tianjin 17
Chengdu 16
Chicago 16
Duncan 16
Shenyang 16
Toulouse 16
Buffalo 15
Ottawa 15
Redmond 15
San Mateo 15
Toronto 15
Hong Kong 14
Naples 14
New Haven 14
Norwalk 14
Pittsburgh 14
Rochester 14
Xian 13
Dallas 12
Dunedin 12
Moscow 12
Phoenix 12
Rehovot 12
Seoul 12
Frankfurt am Main 11
Melbourne 11
Somerville 11
Washington 11
Budapest 10
Chennai 10
Dong Ket 10
Grafing 10
Lyngby 10
Shenzhen 10
Zhengzhou 10
Birmingham 9
Fuzhou 9
Jerusalem 9
Madrid 9
Totale 4.874
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.941
Adaptive mutability of colorectal cancers in response to targeted therapies 1.892
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 703
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 590
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 460
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 382
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 301
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 264
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 248
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 228
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 210
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 199
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 181
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 172
Tracking colorectal cancer evolution in time and space 157
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer 153
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 103
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy 99
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer 93
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 75
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer 72
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 71
Graves' disease prevalence in a young population with Turner syndrome 70
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 65
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells 52
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 50
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients 48
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 28
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 27
Abstract A120: Adaptive mutability of colorectal cancers in response to targeted therapies 22
DNA demethylation triggers cell free DNA release in colorectal cancer cells 20
Abstract 6262: Emergence of tumor mismatch repair deficiency and increased mutational burden in blood and tissue of metastatic colorectal cancer patients treated with temozolomide 19
Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 19
Abstract 6402: The effects of cytotoxic chemotherapy on colorectal cancer immunogenicity 17
Mutational signatures of colorectal cancers according to distinct computational workflows 17
Abstract A001: Reshaping the immune microenvironment after temozolomide priming in metastatic colorectal cancer patients in ARETHUSA clinical trial 15
Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer 15
null 15
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial 15
Abstract B11: Whole-exome sequencing analysis of urine transrenal tumor DNA in metastatic colorectal cancer patients 15
Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations 15
Raise and decline of KRAS mutant clones in colorectal cancers (CRCs) treated with multiple rounds of anti-EGFR antibodies 14
Abstract 2913: Emergence of RAS or EGFR mutant clones affects duration of response to EGFR blockade in colorectal cancers 14
Abstract 5284: Immune surveillance of chemotherapy-induced mutant subclones in CRC 14
Abstract 2848: Radiographic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer 14
Sequence Analysis of 96 Genomic Regions Identifies Distinct Evolutionary Lineages within CC156, the Largest Streptococcus pneumoniae Clonal Complex in the MLST Database 13
Abstract 2613: A modified Luria-Delbrück assay allows quantification of colorectal cancer persister cells’ mutation rate 12
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 12
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 12
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 12
Abstract 3834: Tracking CAD-ALK gene translocation in urine and plasma of a colorectal cancer patient treated with ALK blockade 11
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 11
An extended multi-locus molecular typing schema for Streptococcus pneumoniae demonstrates that a limited number of capsular switch events is responsible for serotype heterogeneity of closely related strains from different countries 11
Abstract 616: Blood-based molecular landscapes of resistance to EGFR blockade in colorectal cancer patients 10
Abstract 878: Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer 10
Editorial: The impact of genetics on CRC therapy: from adaptive mutability to drug resistance 10
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer 10
Assessment of HER2 (ERBB2) amplification (HER2amp) using blood-based circulating tumor DNA (ctDNA) next generation sequencing (NGS) and correlation with tissue-based testing in metastatic colorectal cancer (mCRC) 7
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 2
Totale 9.337
Categoria #
all - tutte 20.909
article - articoli 0
book - libri 0
conference - conferenze 1.699
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020514 0 0 0 0 0 67 59 61 98 103 84 42
2020/20211.420 50 69 81 141 134 120 145 94 126 164 131 165
2021/20221.686 184 167 155 221 85 102 120 112 124 99 178 139
2022/20231.650 109 122 123 155 121 196 122 164 181 89 147 121
2023/20241.449 118 132 126 110 110 134 134 110 38 143 143 151
2024/20251.298 76 104 294 236 401 187 0 0 0 0 0 0
Totale 9.337